41 /100
MEDIUM RISK
Score updated Apr 28, 2026

XLO

Xilio Therapeutics, Inc. — Stock Dilution Tracker

Track XLO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track XLO — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $10M remaining capacity
🔔 Track XLO — Get forecast alerts →
💹 Market Data
Market Cap$45.80M
Shares Outstanding5.78M
Float3.45M
Cash$137.53M
Debt$6.95M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 80.0% shares (2025Q4 vs prior)
37 institutional holders · 39.73M shares
#1 GILEAD SCIENCES, INC. 9.11M shares
#2 Bain Capital Life Sciences Investors, LLC 7.37M shares
#3 Frazier Life Sciences Management, L.P. 5.92M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest174.3K
Days to Cover5.9
% of Float5.1%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Mar 30, 2026
4 INSIDER TRANSACTION Feb 17, 2026
8-K 8K EVENT Feb 12, 2026
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track XLO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking XLO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for XLO
📊 XLO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 XLO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.